These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6330746)

  • 1. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
    Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNA.
    Szigeti R; Saemundsen AK; Synnerholm AC; Henle G; Henle W; Klein G
    Cancer Res; 1983 May; 43(5):2273-6. PubMed ID: 6299543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membranes of EBV-carrying virus nonproducer cells inhibit leukocyte migration of EBV-seropositive but not seronegative donors.
    Szigeti R; Volsky DJ; Luka J; Klein G
    J Immunol; 1981 May; 126(5):1676-9. PubMed ID: 6260854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
    Szigeti R; Timar L; Weiland O; Henle W; Henle G; Hennessy K; Kieff E; Sulitzeanu D; Dillner J; Klein G
    Clin Immunol Immunopathol; 1986 Dec; 41(3):342-50. PubMed ID: 3022972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
    Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP).
    Sulitzeanu D; Szigeti R; Hatzubai A; Dillner J; Hammarskjöld ML; Klein G; Klein E
    Immunol Lett; 1988 Aug; 18(4):301-6. PubMed ID: 2846438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of cell-mediated immunity to Epstein-Barr herpesvirus by cell migration inhibition tests.
    Lai PK; Alpers MP; Mackay Scollay EM
    J Natl Cancer Inst; 1975 Dec; 55(6):1319-22. PubMed ID: 173867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migration inhibition caused by EBV-specific 48K subcomponent of EBNA and the associated 53K cellular protein.
    Szigeti R; Luka J; Sternås L; Klein G
    Int J Cancer; 1982 Apr; 29(4):413-6. PubMed ID: 6282766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor.
    Szigeti R; Luka J; Klein G
    Cell Immunol; 1981 Mar; 58(2):269-76. PubMed ID: 6260386
    [No Abstract]   [Full Text] [Related]  

  • 13. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence.
    Pearson G; Klein G; Henle G; Henle W; Clifford P
    J Exp Med; 1969 Apr; 129(4):707-18. PubMed ID: 4886045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    Miller G; Coope D; Niederman J; Pagano J
    J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
    Pearson GR; Orr TW
    J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.
    Kishishita M; Luka J; Vroman B; Poduslo JF; Pearson GR
    Virology; 1984 Mar; 133(2):363-75. PubMed ID: 6324457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
    Qualtiere LF; Pearson GR
    Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.